Browse All

Current Filters

CLEAR FILTER x

TITLE

Identifying Challenges to MSCopilot® 's Integration into Multiple Sclerosis Standard Clinical Practice: Methodology of MS-FLOWER, An Ongoing U.S. Multicenter Pilot Study

Ofatumumab Treatment Up to Eight Years Shows a Favorable and Consistent Safety Profile in People Living With Relapsing Multiple Sclerosis